Almost 2,300 clinical trials to be conducted in Central Europe in 2014

The Central European (CE) region has, in recent years, been extensively affected by changes in global trends relating to clinical trials, mainly because of the regulatory and economic developments in the countries involved. Rising costs have forced global concerns to increase their total spending on R&D, notes a new report from Poland-based market research group PMR.

As a consequence, global outsourcing trends have become more prevalent in recent decades, particularly on markets such as CE which are strategically important. In total, the number of new clinical trials is expected to rise by 6-7% per annum between 2012 and 2014. Most will be phase III oncology studies.

CE region attractive but increasingly mature